Home

Nir Sassi

CIK 1760673 · Chief Financial Officer · last filed 2025-12-29

Nir Sassi is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider was granted $54.3K of INDP on Dec 29, 2025. Current disclosed insider exposure totals $34.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$34.5K

Companies

2

Total Filings

11

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INDP Chief Financial Officer 26,758 $1.29 $34.5K $0 7 2025-12-29
Intec Pharma Ltd. (NTEC) Delisted Chief Financial Officer — $9.63 — $0 4 2020-09-18

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-29 INDP Grant (A) +26,758 $54.3K EDGAR
2025-04-11 INDP Disp (D) — $0 EDGAR
2024-10-10 INDP Grant (A) — $0 EDGAR
2024-01-23 INDP Grant (A) — $0 EDGAR
2023-01-20 INDP Grant (A) — $0 EDGAR
2022-02-28 INDP Grant (A) — $0 EDGAR
2021-08-06 INDP Grant (A) — $0 EDGAR
2020-09-18 Intec Pharma Ltd. (NTEC) Delisted Grant (A) — $0 EDGAR
2020-02-19 Intec Pharma Ltd. (NTEC) Delisted Grant (A) — $0 EDGAR
2019-09-16 Intec Pharma Ltd. (NTEC) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.